Onyvax Limited

USPTO Granted Patents = 7

EPO Patents = 1

Forward Citations = 21

Loading Chart...

5 inventors (with patents filed for the assignee):

Angus Dalgleish (6 out of 17 patents)

Anthony Ian Walker (6 out of 7 patents)

Andrew Derek Sutton (4 out of 4 patents)

4. Peter Michael Smith (3 out of 3 patents)

5. Peter Thraves (1 out of 1 patent)

6. Peter Onyvax Limited Thraves (0 patent)

7. Andrew Onyvax Limited Sutton (0 patent)

7 patents: Sort by Forward Citations

1. 8545835 - Human prostate cell lines in cancer treatment (2013-10-01),

2. 8097244 - Human prostate cell lines in cancer treatment (2012-01-17),

3. 8034360 - Use of human prostate cell lines in cancer treatment (2011-10-11),

4. 7438922 - Human prostate cell lines in cancer treatment (2008-10-21),

5. 7303911 - Prostate cell lines (2007-12-04),

6. 6972128 - Use of human prostrate cell lines in prostate cancer treatment (2005-12-06),

7. 6699483 - Cancer treatments (2004-03-02),

Onyvax Limited is a biotechnology company specializing in the development of cancer vaccines. The company's innovative approach focuses on creating personalized immunotherapies to target a wide array of cancer types. Onyvax's cutting-edge research and development efforts aim to revolutionize cancer treatment and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

7 Patents

#199 in

#2,298 in United Kingdom

GB